Haemonetics says FDA clears vascular closure device

Haemonetics said on Monday the US ​Food and Drug Administration approved its device designed to seal arterial openings ‌created during minimally invasive heart and vascular procedures.

Unilever to sell Welly bandage brand to Forward Consumer Partners

Unilever said on Monday it has ​agreed to sell Welly Health PBC to private-equity firm Forward Consumer ‌Partners, but did not disclose financial terms of ⁠the sale.

Trump to create new NIH division, task force for women's health

President Donald Trump will sign an executive order alongside first lady Melania Trump on Monday ​creating a task force and a National Institutes of Health division focused on women's health, the White House said.

Germany's Merck buys Silence Therapeutics in $1.3 billion RNA drug deal

German drugmaker Merck KGaA said on Monday it would acquire UK-based Silence ​Therapeutics in an all-cash deal for about $1.3 billion, bolstering its pipeline of precision medicines and adding RNA-targeting drug technology.

EyePoint to halve workforce after experimental drug fails second late-stage trial

EyePoint on Monday said it would cut about ​53% of its workforce and stop studies of its experimental drug for an age-related vision disease ‌after a second late-stage trial failed.

Veradermics' oral hair-loss drug shown to boost hair growth in late-stage study

Drug developer Veradermics said on Monday that ​its oral pill helped increase hair growth in men with pattern hair loss in a late-stage study.

Gilead's pill succeeds in mid-stage bowel disease trial

Gilead Sciences said on Monday its experimental once-daily ​pill reduced symptoms of a chronic bowel illness in more patients than placebo in ‌a mid-stage trial.

China's Hansoh Pharma strikes drug deal with Roche worth over $15 billion

China's Hansoh Pharmaceutical said on Monday it has entered into a partnership and ​licensing deal with Roche potentially worth more than $15 billion that covers a portfolio of antibody-drug conjugate programs.